| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $-0.0B | $0.0B | $-0.0B | $-0.0B |
| EPS (Basic) | $-2.47 | $1.25 | $1.50 | $1.37 |
| EPS (Diluted) | $-2.47 | $1.25 | $1.50 | $1.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $0.3B | $0.4B | $0.5B | $0.5B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $0.2B | $0.3B | $0.3B | $0.3B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $0.1B | $0.2B | $0.2B | $0.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.1B | $0.0B |
| Investing Cash Flow | — | — | — | — |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $-0.0B | $-0.1B | $-0.1B | $-0.0B |